Hotta, K., Nishio, M., Saito, H., Okamoto, I., Nakahara, Y., Hayashi, H., . . . Azuma, K. (2021). First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis. Int J Clin Oncol.
Παραπομπή Chicago StyleHotta, Katsuyuki, et al. "First-line Durvalumab Plus Platinum-etoposide in Extensive-stage Small-cell Lung Cancer: CASPIAN Japan Subgroup Analysis." Int J Clin Oncol 2021.
Παραπομπή MLAHotta, Katsuyuki, et al. "First-line Durvalumab Plus Platinum-etoposide in Extensive-stage Small-cell Lung Cancer: CASPIAN Japan Subgroup Analysis." Int J Clin Oncol 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.